Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA) Stock Price & Growth Analysis

Quote Panel

Updated August 10, 2025

1W 9.67 % 1M 9.31 % 3M 12.82 % 1Y 1.09 %

Key Metrics

Market Cap
1.52B
Shares Outstanding
149.00M
Share in Float
71.26M
Dividende
0.36331

Earning Date
12 Aug 2025
Price Target
10.21
Average Volume
443578
Beta
0.403

Range
7.83-11.18
Industry
Drug Manufacturers - General
Website
https://www.dimed.com.br
Sector
Healthcare

Quote Panel

Updated August 10, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

15.65x

P/E Ratio

0.31x

P/S Ratio

1.22x

P/B Ratio

1.0

Debt/Equity

2.0%

Net Margin

$0.6

EPS

How PNVL3.SA compares to sector?

P/E Ratio

Fundamentals

Relative Strength

PNVL3.SA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

PNVL3.SA

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$6B

393%

2026-Revenue

$1.35

694%

2026-EPS

$518M

340%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.22

+4%

0.16
vs 0.16

Q1.23

-14%

0.12
vs 0.14

Q2.23

-6%

0.15
vs 0.16

Q3.23

+33%

0.16
vs 0.12

Q4.23

+20%

0.19
vs 0.16

Q1.24

+88%

0.23
vs 0.12

Q2.24

-77%

0.03
vs 0.15

Q3.24

+50%

0.24
vs 0.16

Q4.24

+7%

0.21
vs 0.19

Q1.25

-25%

0.17
vs 0.23

Sales Growth

YoY

Current

Estimates

Q1.23

+14%

1B vs 901.5M

Q2.23

+10%

1.1B vs 986.3M

Q3.23

+11%

1.1B vs 1B

Q4.23

+13%

1.2B vs 1.1B

Q1.24

+19%

1.2B vs 1B

Q2.24

+5%

1.1B vs 1.1B

Q3.24

+9%

1.2B vs 1.1B

Q4.24

+10%

1.3B vs 1.2B

Q1.25

+3%

1.3B vs 1.2B

Q2.25

+24%

1.4B vs 1.1B

Return on Equity

QoQ

Q4.22

+2%

0.02
vs 0.02

Q1.23

+2%

0.02
vs 0.02

Q2.23

+2%

0.02
vs 0.02

Q3.23

+2%

0.02
vs 0.02

Q4.23

+2%

0.02
vs 0.02

Q1.24

+3%

0.03
vs 0.02

Q2.24

+0%

0
vs 0.03

Q3.24

+3%

0.03
vs 0

Q4.24

+3%

0.03
vs 0.03

Q1.25

+2%

0.02
vs 0.03

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q4.22

+4%

0.16
vs 0.16

Q1.23

-14%

0.12
vs 0.14

Q2.23

-6%

0.15
vs 0.16

Q3.23

+33%

0.16
vs 0.12

Q4.23

+20%

0.19
vs 0.16

Q1.24

+88%

0.23
vs 0.12

Q2.24

-77%

0.03
vs 0.15

Q3.24

+50%

0.24
vs 0.16

Q4.24

+7%

0.21
vs 0.19

Q1.25

-25%

0.17
vs 0.23

Sales Growth

YoY

Current

Estimates

Q1.23

+14%

1B vs 901.5M

Q2.23

+10%

1.1B vs 986.3M

Q3.23

+11%

1.1B vs 1B

Q4.23

+13%

1.2B vs 1.1B

Q1.24

+19%

1.2B vs 1B

Q2.24

+5%

1.1B vs 1.1B

Q3.24

+9%

1.2B vs 1.1B

Q4.24

+10%

1.3B vs 1.2B

Q1.25

+3%

1.3B vs 1.2B

Q2.25

+24%

1.4B vs 1.1B

Return on Equity

QoQ

Q4.22

+2%

0.02
vs 0.02

Q1.23

+2%

0.02
vs 0.02

Q2.23

+2%

0.02
vs 0.02

Q3.23

+2%

0.02
vs 0.02

Q4.23

+2%

0.02
vs 0.02

Q1.24

+3%

0.03
vs 0.02

Q2.24

+0%

0
vs 0.03

Q3.24

+3%

0.03
vs 0

Q4.24

+3%

0.03
vs 0.03

Q1.25

+2%

0.02
vs 0.03

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Company Description

10.21BRL

15.65x

0.31x

1.22x

1.0

2.0%

$0.6

$6B

$1.35

$518M

Earnings Growth

Latest News

Latest News

Latest News

$6B

$1.35

$518M

Earnings Growth

Company Description

10.21BRL

15.65x

0.31x

1.22x

1.0

2.0%

$0.6